ACGT ProGenomics AG, november deal

NBX acquired 25% of ACGT ProGenomics, a recombinant protein and drug delivery company, for 240,000 NBX shares, valued at $670,000 based on NBX's Friday close at 6.12DM (US$2.80). NBX has exclusive glo...